From Reuters.

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the US by 2030, it said, the latest big investment by a pharmaceutical company reacting to President Trump’s tariff policy.
#News #AstraZeneca #US #Trump #tariff #Reuters #Newsfeed

Read the story here: https://reut.rs/3IUFOi2

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en